Clinical trial

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers…

NCT00392743 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00392743
Title A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
Official title An Open-label, Cross-over Study, to Compare the PET and SPECT Measurement of Antipsychotic-induced D2 Receptor Occupancy, in a Group of Healthy Volunteers and in Another Group of Patients With Schizophrenia and Other Psychotic Disorders
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Study type Observational
Conditions Schizophrenia
Intervention type Procedure
Interventions pet/spect scan
Enrollment 60
Start date Dec 1, 2006
Primary completion May 1, 2007
Completion May 1, 2007
First posted Oct 26, 2006
Last update posted Nov 5, 2012
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies